$OPK

$1.61 -$0.02 (1.23%) Close

$OPK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$OPK Management Team

Dr. Phillip Frost

Chairman of the Board

Chief Executive Officer

Age 88

Compensation $2.164M USD

Sex Male

Dr. Elias Zerhouni

President

Vice Chairman of the Board

Age 74

Compensation $2.074M USD

Sex Male

Mr. Adam Logal

Chief Financial Officer

Senior Vice President

Chief Accounting Officer

Treasurer

Age 46

Compensation $1.810M USD

Sex Male

Dr. Jane Hsiao

Vice Chairman of the Board

Chief Technical Officer

Age 77

Compensation $2.074M USD

Sex Female

Dr. Charles Bishop

Chief Executive Officer of OPKO Renal

Age 73

Compensation -

Sex Male

Dr. Tony Cruz

Chief Executive Officer

Transition Therapeutics

Inc

Age 71

Compensation -

Sex Male

Mr. Steven Rubin

Executive Vice President - Administration

Director

Age 64

Compensation $1.845M USD

Sex Male

Dr. Gary Nabel

Chief Innovation Officer

Director

Age 71

Compensation -

Sex Male

Ms. Yvonne Briggs

Investor Relations

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Phillip Frost Chairman of the Board Chief Executive Officer	88	$2.164M USD	Male
Dr. Elias Zerhouni President Vice Chairman of the Board	74	$2.074M USD	Male
Mr. Adam Logal Chief Financial Officer Senior Vice President Chief Accounting Officer Treasurer	46	$1.810M USD	Male
Dr. Jane Hsiao Vice Chairman of the Board Chief Technical Officer	77	$2.074M USD	Female
Dr. Charles Bishop Chief Executive Officer of OPKO Renal	73	-	Male
Dr. Tony Cruz Chief Executive Officer Transition Therapeutics Inc	71	-	Male
Mr. Steven Rubin Executive Vice President - Administration Director	64	$1.845M USD	Male
Dr. Gary Nabel Chief Innovation Officer Director	71	-	Male
Ms. Yvonne Briggs Investor Relations	-	-	Female

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 5 not stated

Average tenure

12.2 years

from year joined

CEO also chairs the board

Yes

Phillip Frost

Director	Age	On board	Independent	Committees	Other public boards	Pay
Phillip Frost Board chair, CEO, Executive officer	89	2007 19 years	Not stated	None stated	Cocrystal Pharma, Inc.	Paid as CEO
Jane H. Hsiao Executive officer	78	2007 19 years	Not stated	None stated	None stated	Not stated
Elias A. Zerhouni Executive officer	75	2022 4 years	Not stated	None stated	Danaher Corporation	Not stated
Steven D. Rubin Executive officer	65	2007 19 years	Not stated	None stated	Entera Bio Ltd	Not stated
Gary J. Nabel	72	2022 4 years	Not stated	None stated	SIGA Technologies, Inc.	Not stated
Prem A. Lachman	65	2021 5 years	Independent	Audit Compensation	None stated	Not stated
Roger J. Medel	79	2020 6 years	Independent	Compensation	None stated	Not stated
John A. Paganelli	91	2003 23 years	Independent	Audit	None stated	Not stated
Richard C. Pfenniger, Jr.	70	2008 18 years	Independent	Audit · Chair	Cocrystal Pharmaceuticals, Inc.	Not stated
Subbarao V. Uppaluri	76	2026 0 years	Independent	Compensation · Chair	None stated	Not stated
Alice Lin-Tsing Yu	82	2009 17 years	Independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$OPK Management Team

Dr. Phillip Frost

Dr. Elias Zerhouni

Mr. Adam Logal

Dr. Jane Hsiao

Dr. Charles Bishop

Dr. Tony Cruz

Mr. Steven Rubin

Dr. Gary Nabel

Ms. Yvonne Briggs

Board of Directors

Related-party transactions

No related-party transactions disclosed